Exclusive Content
Lundbeck and EVERSANA Enter Strategic Partnership to Advance AI-Powered Commercialization Across U.S. Operations
Lundbeck, a global biopharmaceutical leader focused exclusively on brain health, and EVERSANA®, a leading global provider of commercial services to the life sciences sector,...
Montage Laboratories Commences Construction of Manufacturing Unit 3 to Expand Production Footprint
Montage Laboratories Pvt. Ltd., a manufacturer of pharmaceutical formulations, has performed the Bhoomi Pujan(groundbreaking ceremony) for its upcoming manufacturing facility, Unit 3. The milestone marks a new phase in the...
AIIA Rolls Out “Garbhini Mitra” Programme to Widen Community-Level Maternal Support Through Ayurveda
The All India Institute of Ayurveda (AIIA) in New Delhi, an autonomous body under the Ministry of Ayush, has launched a new skill-development course called Garbhini Mitra for...
GSK’s Hibsago Becomes World’s First Approved Functional Cure for Chronic Hepatitis B
GSK has secured its first global regulatory approval for Hibsago(bepirovirsen), marking the debut of a functional cure option for chronic hepatitis B (CHB) anywhere in...
Fortis Healthcare Launches Lung Failure Clinics in New Delhi to Enhance Advanced Respiratory and Transplant Care
Fortis Healthcare has announced the launch of dedicated Lung Failure Clinics at its Shalimar Bagh and Vasant Kunj facilities in New Delhi. The initiative establishes a specialized, multidisciplinary...
Symbiotec Pharmalab Announces ₹1,757 Crore IPO to Fuel Biopharma Growth
Symbiotec Pharmalab, a leading research and development-driven pharmaceutical and biotechnology player, has announced details of its ₹1,757 crore Initial Public Offering (IPO). The public issue...
